Sandra Horning - 14 Jun 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Reporting relationship: Director
Issuer ticker: OLMA
Reported as of: 14 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2024, 17:00:25 UTC
Prior SEC filing: 09 May 2024
Next SEC filing: 24 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Shane Kovacs, Attorney-in-Fact

Key filing fact

Sandra Horning filed Form 4 for Olema Pharmaceuticals, Inc. (OLMA) on 18 Jun 2024.

Key facts

This page summarizes Sandra Horning's Form 4 filing for Olema Pharmaceuticals, Inc. (OLMA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jun 2024, 17:00.

Change

Previous filing in this sequence was filed on 09 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OLMA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +23,000
Change %
Price: $0.000000
Shares after: 23,000
Date: 14 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,000
Exercise price: $12.36
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.